Evidence map›Paper›PMID 42552333›Full record

ArticleScientific reports2026

Exonisation of an Alu element in the 3'-UTR contributes to SRD5A2 deficiency.

Ralf Werner, Anna Basina, Axel Künstner, Sudharsan Agas Chandra Prakash, Kübra Kösem, Alexandra Kulle, Nadine C Hornig, Stefan A Wudy, Michaela F Hartmann, Paul-Martin Holterhus and 2 more

Abstract readCase Reports
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ralf WernerDivision of Paediatric Endocrinology and Diabetology, Universität zu Lübeck, 23562, Lübeck, Germany. ralf.werner@uni-luebeck.de.ORCID 0000-0003-3718-3595
Anna BasinaDivision of Paediatric Endocrinology and Diabetology, Universität zu Lübeck, 23562, Lübeck, Germany.
Axel KünstnerGroup of Medical Systems Biology, Lübeck Institute of Experimental Dermatology, Universität zu Lübeck, Lübeck, Germany.ORCID 0000-0003-0692-2105
Sudharsan Agas Chandra PrakashDivision of Paediatric Endocrinology and Diabetology, Universität zu Lübeck, 23562, Lübeck, Germany.ORCID 0009-0007-0423-0769
Kübra KösemDivision of Paediatric Endocrinology and Diabetology, Universität zu Lübeck, 23562, Lübeck, Germany.
Alexandra KulleDepartment of Pediatric Oncology and Rheumatology, Paediatric Endocrinology and Diabetes, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Kiel, Germany.
Nadine C HornigInstitute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0003-2469-752X
Stefan A WudySteroid Research and Mass Spectrometry Unit, Laboratory for Translational Hormone Analytics, Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany.
Michaela F HartmannSteroid Research and Mass Spectrometry Unit, Laboratory for Translational Hormone Analytics, Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany.
Paul-Martin HolterhusDepartment of Pediatric Oncology and Rheumatology, Paediatric Endocrinology and Diabetes, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Kiel, Germany.
Hauke BuschGroup of Medical Systems Biology, Lübeck Institute of Experimental Dermatology, Universität zu Lübeck, Lübeck, Germany.ORCID 0000-0003-4763-4521
Olaf HiortDivision of Paediatric Endocrinology and Diabetology, Universität zu Lübeck, 23562, Lübeck, Germany.ORCID 0000-0001-7490-4983

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Steroid 5α-reductase deficiency is a rare autosomal recessive condition caused by mutations in the SRD5A2 gene that leads to a severe virilisation deficit of the external genitalia in individuals with a 46,XY karyotype. Here we report an adult 46,XY person with clinically confirmed steroid 5α-reductase deficiency. Sanger sequencing revealed a compound heterozygous, maternal, pathogenic c.692A > G; p.(His231Arg) variant and a very rare paternal c.*66T > G variant in the 3'-UTR. RT-PCR products of individual's derived genital skin fibroblasts revealed that only the maternal variant is expressed while the paternal variant could not be detected. PacBio RNA Isosequencing revealed that the variant c.*66T > G introduces a new strong splice donor site 66 nt after the canonical stop codon that is spliced to an inverted Alu sequence located 15 kb downstream. In all paternal, but none of the maternal transcripts, we found a new exon junction 66 nt after the stop codon within the 3'-UTR. Mammalian transcripts with an intron excision site > 55 nt downstream from a termination codon are subject to degradation by the nonsense-mediated decay (NMD) pathway. We conclude that the pathogenic maternal variant, together with the NMD-triggered downregulation of the paternal allele, is causative for the observed SRD5A2 deficiency.

Indexed as

3-Oxo-5-alpha-Steroid 4-Dehydrogenase3' Untranslated RegionsAlu ElementsExonsMembrane ProteinsAdultBase SequenceHumansMaleMutation3-Oxo-5-alpha-Steroid 4-Dehydrogenase3' Untranslated RegionsMembrane ProteinsSRD5A2 protein, humanAlu exonisationDifferences of sex developmentNonsense-mediated decaySRD5A2 deficiency

Identifiers

PMID42552333
PMCPMC13438754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.